drug pricing control order
TRANSCRIPT
IMPACT OF NLEM-2015 ON PHARMACEUTICAL INDUSTRY
PRESENTED BY:AMAN DUBE (QA-04)RIDDHI DESAI(QA-03)RUQAIYA VASI (QA-17)IAN FERNANDIS (QA-20)KANJANI SHAH(QA-15)
NLEM 2015
The health ministry has revised its National List of Essential
Medicines (NLEM) to include 376 drugs in the new NLEM 2015 list.
While a total of 106 medicines have been added, 70 medicines have been deleted to finalize the
new list.
VALUE LOST ON INCREMENTAL PRICES CAPPED AS PER REVISED NLEM LIST
VOLUME GROWTH TRENDS
PRICING GROWTH TRENDS
EFFECT ON THERAPEUTIC CATEGORIES
CIPLA SALES GROWTH TRENDS
Source: IMS
124%
217%
322%
419%
518%
ABACAVIR
12345
1 = 20112 = 20123 =20134 = 20145 = 2015
Source : IMS
112%
217%
320%
425%
527%
TENOFOVIR
12345
REVENUE CONTRIBUTION OF MOLECULES OF CIPLA
Source: IMS
Source : IMS
ANTICANCER DRUGS
INCLUDED IN NLEM 2015
Comparison of Pfizer growth with other MNCs
IMPACT OF NLEM 2015 ON PFIZER
Cardiac segment
Anti-infective segment Anti-infective segmentMolecule wise sales
Anti- diabetic segment
ACUTE/ CHRONIC BREAK UP
PRE-NLEM: Rise the price to harvest maximum profit.
POST-NLEM: If increase in volume will maintain the profit, then promotion should not be stopped.
Keep the margin same for distributor and retailer to maintain good relationship with them.
Start focusing on Semi regulated countries.
Product Line extension.
STRATERGY FOR PFIZER AND CIPLA
MNC
Thank You